<DOC>
	<DOC>NCT00676091</DOC>
	<brief_summary>The purpose of this study will be to analyze 13-valent pneumococcal vaccine given to healthy infants in Brazil for safety and tolerability, and to determine the immune response to the vaccines.</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion criteria: Healthy 1 month old infants Available for the duration of the study and reachable by telephone Able to complete two blood drawing procedures during the study Exclusion criteria: Previous vaccination, contraindication or history of allergic reaction to vaccine or vaccine components Bleeding disorder, immune deficiency or significant chronic or congenital disease Previous receipt of blood products or immune globulin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>54 Days</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Pneumococcal conjugate vaccine</keyword>
</DOC>